Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

2,466 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Vaccine Attitudes and COVID-19 Vaccine Intentions and Prevention Behaviors among Young People At-Risk for and Living with HIV in Los Angeles and New Orleans.
Swendeman D, Norwood P, Saleska J, Lewis K, Ramos W, SantaBarbara N, Sumstine S, Comulada WS, Jimenez S, Ocasio MA, Arnold EM, Nielsen-Saines K, Fernandez MI, Rotheram-Borus MJ, On Behalf Of The Adolescent Hiv Medicine Trials Network Atn Cares Team. Swendeman D, et al. Among authors: lewis k. Vaccines (Basel). 2022 Mar 9;10(3):413. doi: 10.3390/vaccines10030413. Vaccines (Basel). 2022. PMID: 35335045 Free PMC article.
Optimal strategies to improve uptake of and adherence to HIV prevention among young people at risk for HIV acquisition in the USA (ATN 149): a randomised, controlled, factorial trial.
Swendeman D, Rotheram-Borus MJ, Arnold EM, Fernández MI, Comulada WS, Lee SJ, Ocasio MA, Ishimoto K, Gertsch W, Duan N, Reback CJ, Murphy DA, Lewis KA; Adolescent HIV Medicine Trials Network (ATN) CARES Study Team. Swendeman D, et al. Among authors: lewis ka. Lancet Digit Health. 2024 Mar;6(3):e187-e200. doi: 10.1016/S2589-7500(23)00252-2. Lancet Digit Health. 2024. PMID: 38395539 Free article. Clinical Trial.
Estimating hepatitis C prevalence in the United States, 2017-2020.
Hall EW, Bradley H, Barker LK, Lewis K, Shealey J, Valverde E, Sullivan P, Gupta N, Hofmeister MG. Hall EW, et al. Among authors: lewis k. Hepatology. 2024 May 13. doi: 10.1097/HEP.0000000000000927. Online ahead of print. Hepatology. 2024. PMID: 38739849
Parenchymal obliteration by renal masses: Functional and oncologic implications.
Kazama A, Munoz-Lopez C, Attawettayanon W, Boumitri M, Maina E, Lone Z, Rathi N, Lewis K, Campbell RA, Palacios DA, Kaouk J, Haber GP, Haywood S, Almassi N, Weight CJ, Remer EM, Ward R, Nowacki AS, Campbell SC. Kazama A, et al. Among authors: lewis k. Urol Oncol. 2024 May 9:S1078-1439(24)00439-3. doi: 10.1016/j.urolonc.2024.04.019. Online ahead of print. Urol Oncol. 2024. PMID: 38729867 Free article.
POLARIS: A phase 2 trial of encorafenib plus binimetinib evaluating high-dose and standard-dose regimens in patients with BRAF V600-mutant melanoma with brain metastasis.
Menzies AM, Long GV, Kohn A, Tawbi H, Weber J, Flaherty K, McArthur GA, Ascierto PA, Pfluger Y, Lewis K, Tsai KK, Hamid O, Prenen H, Fein L, Wang E, Guenzel C, Zhang F, Kleha JF, di Pietro A, Davies MA. Menzies AM, et al. Among authors: lewis k. Neurooncol Adv. 2024 Mar 18;6(1):vdae033. doi: 10.1093/noajnl/vdae033. eCollection 2024 Jan-Dec. Neurooncol Adv. 2024. PMID: 38725995 Free PMC article.
2,466 results